Zevtaz 2 gm/0.5 gm Injection 1's

Zevtaz 2 gm/0.5 gm Injection belongs to a class of medication called cephalosporin antibiotics. It is used to treat various bacterial infections in the body. A bacterial infection is a condition in which harmful bacteria grow in the body and cause infection.

Zevtaz 2 gm/0.5 gm Injection contains Ceftazidime and Tazobactam. Ceftazidime works by interfering with the formation of the bacterial cell wall (a protective covering) that is necessary for their survival. Tazobactam decreases bacterial resistance and enhances the activity of Ceftazidime against the bacteria. Together, Zevtaz 2 gm/0.5 gm Injection helps to treat bacterial infections.

Sometimes, you may experience redness and swelling at the injection site, headache, dizziness, nausea, vomiting, diarrhoea, abdominal pain, and muscle spasms. Most of these side effects of Zevtaz 2 gm/0.5 gm Injection do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Before taking Zevtaz 2 gm/0.5 gm Injection, tell your doctor if you are pregnant or breastfeeding. Inform your doctor if you are allergic to any foods or medications. Drive with caution since Zevtaz 2 gm/0.5 gm Injection may cause dizziness. Before taking Zevtaz 2 gm/0.5 gm Injection, inform your doctor about your medical history and other medications you are currently taking in order to rule out any potential negative effects.

Zevtaz 2 gm/0.5 gm Injection is used in the treatment of serious bacterial infections, including those caused by resistant organisms in hospital settings. The detailed uses of Zevtaz 2 gm/0.5 gm Injection are as follows:

• Treats respiratory infections: Zevtaz 2 gm/0.5 gm Injection is effective in managing severe pneumonia, including hospital-acquired cases.
• Manages urinary tract infections: Zevtaz 2 gm/0.5 gm Injection is used for complicated UTIs, especially those involving resistant bacterial strains.
• Controls skin and soft tissue infections: Zevtaz 2 gm/0.5 gm Injection is indicated for cellulitis, infected wounds, and abscesses.
• Treats intra-abdominal infections: Zevtaz 2 gm/0.5 gm Injection is useful in the treatment of serious abdominal infections such as peritonitis.
• Effective against hospital-acquired infections: Zevtaz 2 gm/0.5 gm Injection acts against multidrug-resistant bacteria, including ESBL-producing organisms commonly found in hospital settings.
• Enhances antibacterial action: Zevtaz 2 gm/0.5 gm Injection provides a synergistic effect by inhibiting bacterial enzymes that break down antibiotics, thereby enhancing overall antibacterial activity against a wide range of gram-positive and gram-negative organisms.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Zevtaz 2 gm/0.5 gm Injection will be administered by a healthcare professional.
• Do not self-administer it.

Zevtaz 2 gm/0.5 gm Injection contains Ceftazidime and Tazobactam. Ceftazidime works by interfering with the production of the bacterial cell wall (a protective covering required for survival). Tazobactam reduces bacterial resistance and increases the action of Ceftazidime against bacteria. Together, they aid in the treatment of bacterial infections, including serious, life-threatening infections due to gram-positive bacteria.

Before taking the Zevtaz 2 gm/0.5 gm Injection, inform your doctor about all your medical conditions, sensitivities, and all medications (including herbals and supplements) you are using. If you are pregnant or breastfeeding, inform your doctor before taking Zevtaz 2 gm/0.5 gm Injection. You are recommended to complete the full course of Zevtaz 2 gm/0.5 gm Injection as your doctor prescribes for effective results. Zevtaz 2 gm/0.5 gm Injection should not be administered if you are currently on any vaccinations or are scheduled for the same. Zevtaz 2 gm/0.5 gm Injection should be used with caution in those with Clostridium difficile-associated diarrhoea. Drive only if you are alert, as Zevtaz 2 gm/0.5 gm Injection may cause dizziness.